US · Healthcare

Rosetta Genomics Ltd (ROSGQ)

Diagnostics & Research

Rosetta Genomics Ltd (ROSGQ) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ROSGQ

P/E ratio

18.00

Rosetta Genomics Ltd (ROSGQ) — FAQ

What is ROSGQ's P/E ratio?

The price-to-earnings (P/E) ratio for Rosetta Genomics Ltd (ROSGQ) is 18.00 (data as of 2026-05-23).

Does Rosetta Genomics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Rosetta Genomics Ltd (ROSGQ). Check the MyAverix Finance app for the latest dividend data.

What sector is Rosetta Genomics Ltd in?

Rosetta Genomics Ltd (ROSGQ) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is ROSGQ listed on?

ROSGQ is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)